Advanced search
Start date
Betweenand

Effects of a combined bioactive supplementation over HDL function in statin treated patients

Grant number: 15/18859-3
Support type:Scholarships abroad - Research Internship - Doctorate
Effective date (Start): May 20, 2016
Effective date (End): May 19, 2017
Field of knowledge:Health Sciences - Nutrition
Principal Investigator:Inar Alves de Castro
Grantee:Bianca Scolaro
Supervisor abroad: Edward A. Fisher
Home Institution: Faculdade de Ciências Farmacêuticas (FCF). Universidade de São Paulo (USP). São Paulo , SP, Brazil
Local de pesquisa : New York University, United States  
Associated to the scholarship:14/04247-3 - Combined bioactive approach over atherosclerosis risk biomarkers, BP.DR

Abstract

Atherosclerosis is a complex and multifactorial disease that consists in a chronicinflammation of the artery wall. Lowering LDL cholesterol (LDL-C) is the primary clinicalapproach to prevent cardiovascular events, which is often achieved by statin treatment.However, even patients treated with statins have a considerable residual burden ofcardiovascular risk. Increasing attention has focused on HDL-C raising as acardioprotective measure, although it has become clear that HDL parameters in serumdo not always reflect HDL function. Once HDL loss of function is attributed to oxidativemodification of HDL particle components and to lipid composition and properties, theobjective of the present proposal is to evaluate whether a combined bioactivesupplementation of omega-3 fatty acids, phytosterols and polyphenols from green teawould impact HDL functionality in statin-treated patients.

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
SCOLARO, BIANCA; NOGUEIRA, MARINA S.; PAIVA, ALINE; BERTOLAMI, ADRIANA; BARROSO, LUCIA P.; VAISAR, TOMAS; HEFFRON, SEAN P.; FISHER, EDWARD A.; CASTRO, INAR A. Statin dose reduction with complementary diet therapy: A pilot study of personalized medicine. MOLECULAR METABOLISM, v. 11, p. 137-144, MAY 2018. Web of Science Citations: 2.

Please report errors in scientific publications list by writing to: cdi@fapesp.br.